Cellosaurus P3XBcl-2-13 (CVCL_B6NI)
| Cell line name | P3XBcl-2-13 | |||||||
|---|---|---|---|---|---|---|---|---|
| Accession | CVCL_B6NI | |||||||
| Resource Identification Initiative | To cite this cell line use: P3XBcl-2-13 (RRID:CVCL_B6NI) | |||||||
| Comments | Group: Hybridoma fusion partner cell line. Characteristics: Enhances the outgrowth of hybridomas following somatic fusion with immune lymphocytes isolated from pooled peripheral lymph nodes (PLN) 8-14 days after the initial immunization (PubMed=9309429). Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine. Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:990; BCL2. Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo. Cell type: Plasma cell; CL=CL_0000786. | |||||||
| Disease | Mouse multiple myeloma (NCIt: C125417) | |||||||
| Species of origin | Mus musculus (Mouse)
(NCBI Taxonomy: 10090)
Breed/subspecies: BALB/c. | |||||||
| Hierarchy | Parent: CVCL_4032 (P3X63Ag8.653) Children:
| |||||||
| Sex of cell | Female | |||||||
| Age at sampling | Age unspecified | |||||||
| Category | Cancer cell line | |||||||
| Publications | PubMed=9309429; DOI=10.1089/hyb.1997.16.381 | |||||||
| Cross-references | ||||||||
| Encyclopedic resources | Wikidata; Q112129483 | |||||||
| Entry history | ||||||||
| Entry creation | 17-Mar-2022 | |||||||
| Last entry update | 14-Aug-2025 | |||||||
| Version number | 7 | |||||||